The weighty impact of anti-obesity drugs, also for investors -

The weighty impact of anti-obesity drugs, also for investors

Listen now

Description

Marketing and media campaigns and celebrity endorsements have boosted consumer demand for anti-obesity drugs, boosting the results of the makers of these weight loss pills. Get the full picture and what it means for food sector investing from Agne Rackauskaite, Portfolio Manager at Impax Asset Management, on this Talking Heads podcast with Daniel Morris, Chief Market Strategist. For more insights, visit Viewpoint: https://viewpoint.bnpparibas-am.com/ Download the Viewpoint app: https://onelink.to/tpxq34 Follow us on LinkedIn: https://bnpp.lk/am Hosted by Ausha. See ausha.co/privacy-policy for more information.

More Episodes

See all »

Adding a string to your bow with absolute return fixed income

With the bull market in bonds now behind us and investors looking for effective ways to position portfolios in fixed income, absolute return fixed income strategies offer potential. They seek to reap positive returns regardless of the direction of bond yields. Listen to this Talking Heads podcast...

Published 05/28/24

Talking Heads

Published 05/28/24

US rate cuts would benefit frontier market bonds as well

The prospect of rate cuts by the US Federal Reserve later this year should allow frontier market bonds to build on what has been a months-long run of robust performance according to Guy Tossou, Senior Portfolio Manager for Emerging Market Frontier Debt.Guy tells Andrew Craig, co-Head of the...

Published 05/21/24